News By Tag Industry News News By Place Country(s) Industry News
|  Just Released: "7TM Pharma A/S - Product Pipeline Review - 2012"New Pharmaceuticals market report from Global Markets Direct: "7TM Pharma A/S - Product Pipeline Review - 2012"
By: Fast Market Research, Inc. This report is built using data and information sourced from Global Markets Direct's proprietary databases, 7TM Pharma A/S's corporate website, SEC filings, investor presentations and featured press releases, both from 7TM Pharma A/S and industry-specific third party sources, put together by Global Markets Direct's team. ------------------------------------------------------------ Full Report Details at - http://www.fastmr.com/ ------------------------------------------------------------ Scope * 7TM Pharma A/S - Brief 7TM Pharma A/S overview including business description, key information and facts, and its locations and subsidiaries. * Review of current pipeline of 7TM Pharma A/S human therapeutic division. * Overview of pipeline therapeutics across various therapy areas. * Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. * Product profiles for late stage and clinical stage products of 7TM Pharma A/S with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones. * Recent updates of the 7TM Pharma A/S's pipeline in the last quarter. * Key discontinued and dormant projects. * Latest news and deals relating to the products. Reasons to buy * Evaluate 7TM Pharma A/S's strategic position with total access to detailed information on its product pipeline. * Assess the growth potential of 7TM Pharma A/S in its therapy areas of focus. * Identify new drug targets and therapeutic classes in the 7TM Pharma A/S's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. * Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. * Exploit collaboration and partnership opportunities with 7TM Pharma A/S. * Avoid Intellectual Property Rights related issues. * Explore the dormant and discontinued projects of 7TM Pharma A/S and identify potential opportunities in those areas. Keywords Current R&D Portfolio of 7TM Pharma A/S; 7TM Pharma A/S - Key Therapeutics; Partial Table of Contents: Table of Contents Table of Contents List of Tables List of Figures 7TM Pharma A/S Snapshot 7TM Pharma A/S Overview Key Information Key Facts 7TM Pharma A/S - Research and Development Overview Key Therapeutic Areas 7TM Pharma A/S - Pipeline Review Pipeline Products by Stage of Development Pipeline Products - Monotherapy 7TM Pharma A/S - Pipeline Products Glance 7TM Pharma A/S Clinical Stage Pipeline Products Phase II Products/Combination Treatment Modalities Phase I Products/Combination Treatment Modalities 7TM Pharma A/S - Early Stage Pipeline Products Pre-Clinical Products/Combination Treatment Modalities Discovery Products/Combination Treatment Modalities 7TM Pharma A/S - Drug Profiles Drug For Metabolic Disorders Product Description Mechanism of Action R&D Progress PAD Program Product Description Mechanism of Action R&D Progress TM30339 Product Description Mechanism of Action R&D Progress TM30510 Product Description Mechanism of Action R&D Progress TM38837 Product Description Mechanism of Action R&D Progress 7TM Pharma A/S - Pipeline Analysis 7TM Pharma A/S - Pipeline Products by Therapeutic Class 7TM Pharma A/S - Pipeline Products by Route of Administration 7TM Pharma A/S - Pipeline Products By Mechanism of Action 7TM Pharma A/S - Recent Pipeline Updates 7TM Pharma A/S - Dormant Projects 7TM Pharma A/S - Locations And Subsidiaries Head Office Financial Deals Landscape 7TM Pharma A/S, Deals Summary 7TM Pharma A/S, Pharmaceuticals & Healthcare, Deal Details Venture Financing 7TM Pharma Secures $15 Million In Venture Financing 7TM Pharma Secures $22.3 Million In Financing 7TM Pharma Secures Additional $22.94 Million In Series C Financing Partnerships Dr. Reddy's Labs Signs An Agreement With 7TM Pharma Asset Transactions Prosidion Acquires Pharma Assets From 7TM Pharma Acquisition 7TM Pharma Acquires CareX Appendix Methodology Coverage Secondary Research Primary Research Expert Panel Validation Contact Us Disclaimer List of Tables 7TM Pharma A/S, Key Information 7TM Pharma A/S, Key Facts 7TM Pharma A/S - Pipeline by Indication, 2012 7TM Pharma A/S - Pipeline by Stage of Development, 2012 7TM Pharma A/S - Monotherapy Products in Pipeline, 2012 7TM Pharma A/S - Phase II, 2012 7TM Pharma A/S - Phase I, 2012 7TM Pharma A/S - Pre-Clinical, 2012 7TM Pharma A/S - Discovery, 2012 7TM Pharma A/S - Pipeline By Therapeutic Class, 2012 7TM Pharma A/S - Pipeline By Route of Administration, 2012 7TM Pharma A/S - Pipeline Products By Mechanism of Action, 2012 7TM Pharma A/S - Recent Pipeline Updates, 2012 7TM Pharma A/S - Dormant Developmental Projects,2012 7TM Pharma A/S, Deals Summary 7TM Pharma Secures $15 Million In Venture Financing 7TM Pharma Secures $22.3 Million In Financing 7TM Pharma Secures Additional $22.94 Million In Series C Financing Dr. Reddy's Labs Signs An Agreement With 7TM Pharma Prosidion Acquires Pharma Assets From 7TM Pharma 7TM Pharma Acquires CareX List of Figures 7TM Pharma A/S - Pipeline by Indication, 2012 Full Table of Contents is available at: -- http://www.fastmr.com/ About Global Markets Direct Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number